ORCHPHARMA Financial Statements

ORCHPHARMA Quarterly Results

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2022 Mar-2021 Mar-2020 Mar-2018
Growth matrix (%)        
Revenue growth 24.30 (11) (26) (14)
Op profit growth 6.71 (295) (262) (309)
EBIT growth (43) (65) 30.40 (20)
Net profit growth (98) (11) (63) (29)
Profitability ratios (%)        
OPM 9.50 11.10 (5) 2.30
EBIT margin (4.40) (9.80) (25) (14)
Net profit margin (0.30) (26) (26) (52)
RoCE (2.20) (3.10) (6.30) (3.70)
RoNW (0.10) (4.10) 254 14
RoA -- (2.10) (1.60) (3.40)
Per share ratios ()        
EPS 0.39 (29) (32) --
Dividend per share -- -- -- --
Cash EPS (22) (55) (63) (55)
Book value per share 159 160 188 (89)
Valuation ratios        
P/E 729 (86) -- --
P/CEPS (13) (45) -- (0.20)
P/B 1.79 15.40 -- (0.10)
EV/EBIDTA 22.90 161 -- 83.20
Payout (%)        
Dividend payout -- -- -- --
Tax payout -- -- -- (12)
Liquidity ratios        
Debtor days 99.90 82.60 67.30 75.90
Inventory days 106 119 120 108
Creditor days (100) (96) (157) (217)
Leverage ratios        
Interest coverage 0.78 0.86 30.50 0.32
Net debt / equity 0.40 0.66 0.51 (3.70)
Net debt / op. profit 4.89 8.69 (15) 185
Cost breakup ()        
Material costs (56) (51) (48) (51)
Employee costs (11) (15) (17) (13)
Other costs (23) (23) (40) (34)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2022 Mar-2021 Mar-2020 Mar-2018
Revenue 560 450 508 683
yoy growth (%) 24.30 (11) (26) (14)
Raw materials (314) (229) (243) (350)
As % of sales 56 50.80 47.90 51.30
Employee costs (63) (67) (85) (86)
As % of sales 11.30 14.90 16.70 12.60
Other costs (130) (105) (205) (231)
As % of sales 23.20 23.30 40.40 33.80
Operating profit 53.10 49.80 (25) 15.70
OPM 9.50 11.10 (5) 2.30
Depreciation (87) (109) (126) (133)
Interest expense (32) (51) (4.20) (302)
Other income 9 15.20 24.50 20.30
Profit before tax (57) (95) (131) (399)
Taxes -- -- -- 46.20
Tax rate -- -- -- (12)
Minorities and other 54.90 (21) -- --
Adj. profit (2) (117) (131) (353)
Exceptional items -- -- -- --
Net profit (2) (117) (131) (353)
yoy growth (%) (98) (11) (63) (29)
NPM (0.30) (26) (26) (52)
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2022 Mar-2021 Mar-2020 Mar-2018
Profit before tax (57) (95) (131) (399)
Depreciation (87) (109) (126) (133)
Tax paid -- -- -- 46.20
Working capital (743) (215) 259 (898)
Other operating items -- -- -- --
Operating cashflow (887) (419) 2.06 (1,384)
Capital expenditure (1,437) (1,914) (2,525) (1,483)
Free cash flow (2,325) (2,333) (2,523) (2,866)
Equity raised 1,578 1,761 1,136 (280)
Investments 44.70 14.60 (0.60) 0.26
Debt financing/disposal (1,811) (1,552) (903) 443
Dividends paid -- -- -- --
Other items -- -- -- --
Net in cash (2,514) (2,110) (2,290) (2,703)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2022 Mar-2021 Mar-2020 Mar-2019
Equity capital 109 109 40.80 89
Preference capital -- -- -- --
Reserves 538 544 725 (793)
Net worth 647 653 766 (704)
Minority interest
Debt 268 453 566 3,230
Deferred tax liabilities (net) 86.10 153 201 244
Total liabilities 1,001 1,258 1,533 2,769
Fixed assets 593 678 884 1,534
Intangible assets
Investments 45.50 15.40 0.34 0.47
Deferred tax asset (net) 82.80 149 198 240
Net working capital 272 396 278 669
Inventories 173 153 142 170
Inventory Days 113 124 102 --
Sundry debtors 171 136 68 120
Debtor days 111 110 48.80 --
Other current assets 120 235 192 927
Sundry creditors (168) (110) (102) (302)
Creditor days 109 89.20 73 --
Other current liabilities (24) (18) (23) (245)
Cash 8.06 19.90 174 326
Total assets 1,001 1,258 1,533 2,769
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Mar-2022 Dec-2021 Sep-2021 Jun-2021 Mar-2021
Gross Sales 178 161 128 92.30 120
Excise Duty -- -- -- -- --
Net Sales 178 161 128 92.30 120
Other Operating Income -- -- -- -- --
Other Income 1.75 2.37 68.10 3.12 11.30
Total Income 180 164 196 95.40 131
Total Expenditure ** 155 151 116 95.40 123
PBIDT 24.50 13.10 79.40 0.09 7.49
Interest 4.46 6.78 9.89 10.90 11.90
PBDT 20 6.36 69.50 (11) (4.40)
Depreciation 26.60 20.20 20.10 20.10 20.30
Minority Interest Before NP -- -- -- -- --
Tax -- -- -- -- --
Deferred Tax -- -- -- -- --
Reported Profit After Tax (6.60) (14) 49.40 (31) (25)
Minority Interest After NP -- -- -- -- --
Net Profit after Minority Interest (6.60) (14) 49.40 (31) (25)
Extra-ordinary Items -- -- -- -- --
Adjusted Profit After Extra-ordinary item (6.60) (14) 49.40 (31) (25)
EPS (Unit Curr.) (1.60) (3.40) 12.10 (7.60) (6.10)
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) -- -- -- -- --
Equity 40.80 40.80 40.80 40.80 40.80
Public Shareholding (Number) -- -- -- -- --
Public Shareholding (%) -- -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- -- --
Non Encumbered - % in Total Equity -- -- -- -- --
PBIDTM(%) 13.70 8.14 62.10 0.10 6.26
PBDTM(%) 11.20 3.94 54.40 (12) (3.70)
PATM(%) (3.70) (8.60) 38.70 (33) (21)
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity